Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 14, 2018; 24(10): 1134-1143
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1134
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1134
Figure 2 Survival rates of Budd-Chiari syndrome patients.
A: Comparison of cumulative survival rates of Budd-Chiari syndrome (BCS) between the 188 treated patients and 24 untreated patients. Treated patients had significantly better long-term survival than untreated patients (P = 0.007); B: Comparison of cumulative survival rates of BCS among different treatment modalities. Patients treated by interventional radiology had significantly better long-term survival than patients treated by medicine or surgery (P = 0.002).
- Citation: Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, Xu K. Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center. World J Gastroenterol 2018; 24(10): 1134-1143
- URL: https://www.wjgnet.com/1007-9327/full/v24/i10/1134.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i10.1134